Key points from article :
Deep Longevity is a spinout from Insilico Medicine.
Has developed a new AI system that "can predict an individual’s biological age significantly more accurately than conventional methods."
Will use the technology in a collaboration with Human Longevity, Inc.
HLI has the world’s largest base of sequenced genomes and phenotypic information.
“Our team made several discoveries in the field of deep learning for longevity research in both biomarkers of aging and geroprotector discovery,” said Alex Zhavoronkov, CEO of Deep Longevity.
Wil; provide "longevity as a service" - LAAS.
Investment round led by ETP Ventures and the Human Longevity and Performance Impact Venture Fund.
